Steris (STE) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.47% |
| Dec 31, 2025 | 3.61% |
| Sep 30, 2025 | -31.48% |
| Jun 30, 2025 | 61.05% |
| Mar 31, 2025 | -21.64% |
| Dec 31, 2024 | 32.70% |
| Sep 30, 2024 | -17.42% |
| Jun 30, 2024 | 19.19% |
| Mar 31, 2024 | -12.51% |
| Dec 31, 2023 | 99.35% |
| Sep 30, 2023 | -48.03% |
| Jun 30, 2023 | 30.27% |
| Mar 31, 2023 | 4.97% |
| Dec 31, 2022 | 98.01% |
| Sep 30, 2022 | -55.20% |
| Jun 30, 2022 | 34.95% |
| Mar 31, 2022 | -29.71% |
| Dec 31, 2021 | 42.59% |
| Sep 30, 2021 | 75.87% |
| Jun 30, 2021 | -48.14% |
| Mar 31, 2021 | -8.68% |
| Dec 31, 2020 | 27.02% |
| Sep 30, 2020 | 20.75% |
| Jun 30, 2020 | -32.68% |
| Mar 31, 2020 | 51.71% |
| Dec 31, 2019 | -12.83% |
| Sep 30, 2019 | 37.80% |
| Jun 30, 2019 | -38.89% |
| Mar 31, 2019 | 33.65% |
| Dec 31, 2018 | 6.32% |
| Sep 30, 2018 | 24.95% |